4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001181431-10-036838
SVP & GENERAL COUNSEL acquired 4,101 shares (option exercise)
- SVP & GENERAL COUNSEL disposed of 2,051 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Ozeroff Christopher David · SVP & GENERAL COUNSEL
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2010-07-02 | Exercise or conversion : show line 1 in the form | +4,101 | $0.06 | $246 | 43,809 | D |
| 2010-07-07 | Other disposition : show line 2 in the form | −2,051 | 41,758 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2010-07-02 | Exercise or conversion : show line 3 in the form Option to purchase Common Stock | +4,101 | $0.06 | 2015-01-03 | 4,101 | 0 | D |
Loading xslF345X03/rrd281035.xml…